http://www.fpnotebook.com/
Impetigo
Aka: Impetigo, NonBullous Impetigo, Streptococcal Impetigo, Staphylococcal Impetigo, Common Impetigo- See Also
- Epidemiology
- Preschool children most often affected
- Most common bacterial Skin Infection in children
- Highly contagious
- Spreads across body with scratching (autoinoculation)
- Spreads easily in daycares and schools
- Causes
- Staphylococcus aureus (most common)
- Group A Streptococcus
- Predisposing factors
- Minor Skin Trauma (e.g. abrasions)
- Hot, humid weather
- Poor hygiene
- Daycare attendence
- Over-crowded living conditions
- Comorbid conditions
- Malnutrition
- Atopic Dermatitis
- Dialysis
- Types
- Bullous Impetigo (less common)
- Staphylococcal toxin mediated reaction
- NonBullous Impetigo (>70%): Described below
- Host response to infection
- Primary Impetigo (most common)
- Due to direct spread of infection
- Secondary Impetigo (Common Impetigo)
- Related to underlying secondary Impetigo cause
- Bullous Impetigo (less common)
- Symptoms
- Pruritus is often present
- Signs: Streptococcal Impetigo
- Distribution
- Affects face, extremities and other exposed areas
- Characteristics
- Associated findings
- Distribution
- Signs: Staphylococcal Impetigo
- Similar to Streptococcal Impetigo
- Minimal surrounding erythema
- Lesion more shallow
- Complications
- Poststreptococcal Glomerulonephritis (1-5% of Impetigo)
- Occurs with Streptococcal Impetigo (S. pyogenes)
- Not prevented by antibiotic use
- Poststreptococcal Glomerulonephritis (1-5% of Impetigo)
- Labs: Optional (Impetigo is clinical diagnosis)
- Lesion Gram Stain reveals Gram Positive Cocci
- Lesion culture indications
- Poststreptoccal Glomerulonephritis outbreaks
- Methicillin-Resistant Staphylococcal aureus suspected
- Differential Diagnosis
- Common
- Uncommon
- Acute pustular Psoriasis
- Acute Palmoplantar pustulosis
- Primary cutaneous listeriosis (farmers)
- Sweet's Syndrome
- Pemphigous foliaceus
- Ecthyma
- Discoid Lupus Erythematosus
- Course
- Mild to moderate cases are non-scarring, self limited
- Untreated cases heal in 3-6 weeks
- Management
- Topical therapy (as effective as systemic)
- Mupirocin (Bactroban) 2% ointment
- Applied three times daily to affected area for 10-12 days
- Retapamulin (Altabax) 1% ointment
- Apply twice daily to affected area for 5 days
- Fusidic Acid 2% cream (Not available in United States)
- Apply three times daily to affected area for 10-12 days
- Koning (2002) BMJ 324:203-6
- Mupirocin (Bactroban) 2% ointment
- Systemic Agents
- General
- In most cases, topical agents are preferred
- Systemics indicated in severe or extensive cases
- Preferred systemic agents
- Cephalexin (Keflex)
- Child: 25-50 mg/kg/day divided bid-qid x10 days
- Adult: 250-500 mg PO qid for 10 days
- Dicloxacillin
- Child: 12.5 to 25 mg/kg/day PO divided qid
- Adult: 250-500 mg PO qid for 5-7 days
- Cephalexin (Keflex)
- Other systemic agents with higher resistance rates
- Penicillin VK
- Child: 25 to 50 mg/kg/day divided qid for 10 days
- Adult: 250 mg PO qid for 10 days
- Amoxicillin
- Child: 40 mg/kg/day PO divided tid for 10 days
- Adult: 250 mg PO tid for 10 days
- Erythromycin
- Child: 30-50 mg/kg/day PO divided qid for 10 days
- Adult: 250 mg PO qid for 10 days
- Penicillin VK
- General
- Avoid topical disinfectants (no better than Placebo)
- Hexachlorophene (Phisohex)
- Povidone-Iodine Shampoo offers no benefit
- Topical therapy (as effective as systemic)
- References
- Cydulka in Marx (2002) Rosen's Emergency Med., p. 1639
- Swartz in Mandell (2000) Infectious Disease, p. 1037
- Cole (2007) Am Fam Physician 75(6):859-68
- Brown (2003) Int J Dermatol 42:251-5